The original version of this book was inadvertently published with an incorrect affiliation of the author Mahmood Barani. The affiliation has been corrected with this erratum as follows:

10.1007/978-981-16-6819-7_26

Cite

Citations (1)

Hydrogen adsorption on magnesium-decorated (3, 3) and (5, 0) boron nitride nanotubes

Maryam Kosar Mehdi Noura Abbas Rahdar John F. Trant

Hydrogen is one of the cleanest ways to store energy in a post-fossil fuel economy. However, it can be dangerous as bulk gas and additional methods for hydrogen storage are needed. Physisorption on graphene sheets and nanotubes has been proposed as an effective approach due to their exceedingly high surface area and storage capacity similar to, or exceeding, highly compressed gas. Magnesium-doping has been demonstrated to significantly enhance hydrogen storage on boron-doped graphene sheets, but Mg-doped boron nitride nanotubes (BNNT), a potentially far more promising material due to the inherent dipoles in the surface providing stronger affinity for hydrogen, remain unexplored. In this in silico investigation, both the armchair (3,3) and zigzag (5,0) BNNT architectures, doped with Mg atoms, were examined for hydrogen storage capacity using first-principles density functional theory. Our calculations revealed that highly Mg-doped armchair and zigzag polymorphs of BNNTs could adsorb up to 9.65 and 8.77 weight percent hydrogen respectively, above the targets sought by the US Department of Energy for future hydrogen storage materials.

Physisorption

Zigzag

Cryo-adsorption

10.26434/chemrxiv-2023-03zwx

Cite

Citations (0)

Nanomaterials loaded with Quercetin as an advanced tool for cancer treatment

Journal of Drug Delivery Science and Technology (2022)

Carlos Caro Mehrab Pourmadadi Mohammad Mahdi Eshaghi Erfan Rahmani Shirin Shojaei

Blood circulation

Efflux

10.1016/j.jddst.2022.103938

Cite

Citations (42)

Hydrogen adsorption on magnesium-decorated (3, 3) and (5, 0) boron nitride nanotubes

International Journal of Hydrogen Energy (2023)

Mehdi Noura Maryam Kosar Abbas Rahdar John F. Trant

Physisorption

Cryo-adsorption

10.1016/j.ijhydene.2023.05.117

Cite

Citations (6)

Nanovaccines: Immunogenic tumor antigens, targeted delivery, and combination therapy to enhance cancer immunotherapy

Drug Development Research (2024)

Zohreh Jahanafrooz Fatemeh Oroojalian Ahad Mokhtarzadeh Abbas Rahdar Ana M. Díez‐Pascual

Nanovaccines have been designed to overcome the limitations associated with conventional vaccines. Effective delivery methods such as engineered carriers or smart nanoparticles (NPs) are critical requisites for inducing self-tolerance and optimizing vaccine immunogenicity with minimum side effects. NPs can be used as adjuvants, immunogens, or nanocarriers to develop nanovaccines for efficient antigen delivery. Multiloaded nanovaccines carrying multiple tumor antigens along with immunostimulants can effectively increase immunity against tumor cells. They can be biologically engineered to boost interactions with dendritic cells and to allow a gradual and constant antigen release. Modifying NPs surface properties, using high-density lipoprotein-mimicking nanodiscs, and developing nano-based artificial antigen-presenting cells such as dendritic cell-derived-exosomes are amongst the new developed technologies to enhance antigen-presentation and immune reactions against tumor cells. The present review provides an overview on the different perspectives, improvements, and barriers of successful clinical application of current cancer therapeutic and vaccination options. The immunomodulatory effects of different types of nanovaccines and the nanoparticles incorporated into their structure are described. The advantages of using nanovaccines to prevent and treat common illnesses such as AIDS, malaria, cancer and tuberculosis are discussed. Further, potential paths to develop optimal cancer vaccines are described. Given the immunosuppressive characteristics of both cancer cells and the tumor microenvironment, applying immunomodulators and immune checkpoint inhibitors in combination with other conventional anticancer therapies are necessary to boost the effectiveness of the immune response.

Cancer Immunotherapy

Cancer Therapy

Cancer antigen

10.1002/ddr.22244

Cite

Citations (3)

Progress in natural polymer engineered biomaterials for transdermal drug delivery systems

Materials Today Chemistry (2020)

Vishnu Sankar Sivasankarapillai Sabya Sachi Das Fakhara Sabir M.A. Sundaramahalingam Juan Carlos Colmenares

Natural polymers

10.1016/j.mtchem.2020.100382

Cite

Citations (86)